Swiss pharmaceutical industry through the ages
Switzerland is home to two of the largest pharmaceutical companies in the world and hundreds of other smaller biotechs and service providers. Are there lessons from Switzerland’s rise as a pharma hub over the last century and is the pandemic a reckoning for the industry?
We spoke with Basel-based cultural historian Tobias Ehrenbold in a live Instagram discussion about blockbuster drugs, marketing strategies, environmental scandals, innovations, and the challenges of navigating domestic politics abroad.
More
Ehrenbold is the author of the biography of Samuel Koechlin, who was the first CEO of Ciba-Geigy, which are two Novartis predecessor companies that merged in 1970. He also wrote a volume on Roche in Asia and Oceania in the recently published history book on Roche around the world. He is currently working on a book on the modern history of Basel.
If you missed it live, you can re-watch our discussion below. Follow us on InstagramExternal link for more live talks, photos and videos.
More
Why cars still reign supreme in ‘rail-nation’ Switzerland
More
Azeri fossil-fuel cash cow brings controversy to Switzerland
More
Taxes on pension payments: no problem for the Swiss Abroad
More
Is Switzerland as innovative as it ranks?
More
Why Switzerland’s daycare numbers are rising amid regional divides
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.